JDRF Reports: European Commission Has Approved Forxiga for T1D
Forxiga 10 Mg Dapagliflozin Tablet, 2 X 14 Tablets, Treatment: Type Ii Diabetes Mellitus at Rs 1300/stripe in Nagpur
FDA erweitert Zulassung: Dapagliflozin künftig bei Herzinsuffizienz – auch ohne Diabetes
Efficacy and safety of dapagliflozin treatment for type 2 diabetes mellitus patients with comorbid cardiovascular disease and hypertension - Media Centre | EASD
forxiga® 10 mg Filmtabletten 98 St - shop-apotheke.com
10 Jahre Dapagliflozin für Typ-2-Diabetes, HFrEF und CKD
Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study - The Lancet Diabetes & Endocrinology
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study - The Lancet Diabetes & Endocrinology
Dapagliflozin (Forxiga®) Zulassungsänderung | Gelbe Liste